Der Kaninchen Polyklonal anti-PALLD Antikörper wird verwendet zum Nachweis von PALLD in Proben von Human und Maus. Er wurde validiert für IHC, ELISA und IF.
PALLD
Reaktivität: Human
WB
Wirt: Schaf
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300,ELISA 1:20000,IF 1:50-200
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
PALLD
(Palladin, Cytoskeletal Associated Protein (PALLD))
Andere Bezeichnung
Palladin
Hintergrund
PALLD, KIAA0992, CGI-151, Palladin, SIH002, Sarcoma antigen NY-SAR-77PALLD encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The palladin, cytoskeletal associated protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.